# Acumen Pharmaceuticals, Inc.: filings

ABOS · Nasdaq · CIK 1576885 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abos.md) · [Financials](/companies/abos/financials.md) · [Filings](/companies/abos/filings.md) · [Insiders](/companies/abos/insiders.md)

## Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 120, 144 61, 8-K 55, 3 19, 10-Q 17, CORRESP 8, S-8 7, SC 13G 6, SC 13G/A 6, UPLOAD 6, 10-K 5, DEF 14A 5, DEFA14A 5, EFFECT 5, 424B5 4, ARS 4, S-3 4, DRS 2, DRS/A 2, SC 13D/A 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 3/A 1, 424B3 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRSLTR 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, SC 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:03 ET | [10-Q](/filings/0001628280-26-067276.md) | Quarterly report, period 2026-09-30 | 0001628280-26-067276 |
| 2026-10-26 | 07:09 ET | [8-K](/filings/0001628280-26-067129.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-067129 |
| 2026-09-16 | 09:26 ET | [8-K](/filings/0001628280-26-062137.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-062137 |
| 2026-08-12 | 16:13 ET | [10-Q](/filings/0001628280-26-056199.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056199 |
| 2026-08-12 | 07:02 ET | [8-K](/filings/0001628280-26-055940.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-055940 |
| 2026-06-16 | 07:34 ET | [8-K](/filings/0001628280-26-043416.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-043416 |
| 2026-06-03 | 16:43 ET | [8-K](/filings/0001628280-26-040447.md) | 5.07 Shareholder vote results | 0001628280-26-040447 |
| 2026-05-12 | 17:16 ET | [10-Q](/filings/0001628280-26-034204.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034204 |
| 2026-05-12 | 07:07 ET | [8-K](/filings/0001628280-26-033868.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-033868 |
| 2026-04-23 | 16:30 ET | [DEF 14A](/filings/0001628280-26-026870.md) | Proxy statement, period 2025-12-31 | 0001628280-26-026870 |
| 2026-03-26 | 16:06 ET | [10-K](/filings/0001628280-26-021413.md) | Annual report, period 2025-12-31 | 0001628280-26-021413 |
| 2026-03-26 | 07:04 ET | [8-K](/filings/0001628280-26-021189.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-021189 |
| 2026-03-17 | 16:33 ET | [SCHEDULE 13D/A](/filings/0001104659-26-029538.md) | Ownership report, active investor, amended | 0001104659-26-029538 |
| 2026-03-16 | 07:01 ET | [8-K](/filings/0001628280-26-017885.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-017885 |
| 2026-01-12 | 08:33 ET | [8-K](/filings/0001628280-26-001774.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001774 |
| 2025-11-12 | 16:19 ET | [10-Q](/filings/0001576885-25-000104.md) | Quarterly report, period 2025-09-30 | 0001576885-25-000104 |
| 2025-11-12 | 07:09 ET | [8-K](/filings/0001576885-25-000102.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000102 |
| 2025-11-10 | 08:25 ET | [8-K](/filings/0001628280-25-050800.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050800 |
| 2025-08-12 | 17:05 ET | [10-Q](/filings/0001576885-25-000093.md) | Quarterly report, period 2025-06-30 | 0001576885-25-000093 |
| 2025-08-12 | 08:42 ET | [8-K](/filings/0001576885-25-000091.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000091 |
| 2025-07-15 | 07:30 ET | [8-K](/filings/0001576885-25-000087.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000087 |
| 2025-06-05 | 16:37 ET | [8-K](/filings/0001576885-25-000072.md) | 5.07 Shareholder vote results | 0001576885-25-000072 |
| 2025-05-13 | 16:36 ET | [10-Q](/filings/0001576885-25-000065.md) | Quarterly report, period 2025-03-31 | 0001576885-25-000065 |
| 2025-05-13 | 07:32 ET | [8-K](/filings/0001576885-25-000062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000062 |
| 2025-04-23 | 16:23 ET | [DEF 14A](/filings/0001576885-25-000057.md) | Proxy statement, period 2025-06-04 | 0001576885-25-000057 |
| 2025-03-31 | 16:57 ET | [SCHEDULE 13D/A](/filings/0001415889-25-009256.md) | Ownership report, active investor, amended | 0001415889-25-009256 |
| 2025-03-27 | 16:34 ET | [10-K](/filings/0001576885-25-000049.md) | Annual report, period 2024-12-31 | 0001576885-25-000049 |
| 2025-03-27 | 07:24 ET | [8-K](/filings/0001576885-25-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-25-000044 |
| 2024-11-12 | 16:29 ET | [10-Q](/filings/0001576885-24-000098.md) | Quarterly report, period 2024-09-30 | 0001576885-24-000098 |
| 2024-11-12 | 07:19 ET | [8-K](/filings/0001576885-24-000096.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000096 |
| 2024-08-13 | 16:42 ET | [10-Q](/filings/0001576885-24-000092.md) | Quarterly report, period 2024-06-30 | 0001576885-24-000092 |
| 2024-08-13 | 07:48 ET | [8-K](/filings/0001576885-24-000090.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000090 |
| 2024-06-05 | 16:36 ET | [8-K](/filings/0001576885-24-000067.md) | 5.07 Shareholder vote results | 0001576885-24-000067 |
| 2024-05-14 | 16:47 ET | [10-Q](/filings/0001576885-24-000064.md) | Quarterly report, period 2024-03-31 | 0001576885-24-000064 |
| 2024-05-14 | 07:35 ET | [8-K](/filings/0001576885-24-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000061 |
| 2024-04-22 | 16:30 ET | [DEF 14A](/filings/0001576885-24-000055.md) | Proxy statement, period 2024-06-04 | 0001576885-24-000055 |
| 2024-03-26 | 09:16 ET | [10-K](/filings/0001576885-24-000047.md) | Annual report, period 2023-12-31 | 0001576885-24-000047 |
| 2024-03-26 | 07:42 ET | [8-K](/filings/0001576885-24-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576885-24-000044 |
| 2024-03-19 | 08:05 ET | [8-K](/filings/0001576885-24-000039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000039 |
| 2024-02-01 | 07:16 ET | [8-K](/filings/0001576885-24-000032.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000032 |
| 2024-01-12 | 08:42 ET | [8-K](/filings/0001576885-24-000018.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000018 |
| 2024-01-08 | 08:33 ET | [8-K](/filings/0001576885-24-000015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-24-000015 |
| 2023-12-04 | 07:45 ET | [8-K](/filings/0001576885-23-000068.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000068 |
| 2023-11-13 | 17:10 ET | [8-K](/filings/0001576885-23-000065.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000065 |
| 2023-11-13 | 16:21 ET | [10-Q](/filings/0001576885-23-000062.md) | Quarterly report, period 2023-09-30 | 0001576885-23-000062 |
| 2023-11-13 | 07:20 ET | [8-K](/filings/0001576885-23-000058.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000058 |
| 2023-11-09 | 17:59 ET | [8-K](/filings/0001576885-23-000056.md) | 1.01 Entry into a material agreement | 0001576885-23-000056 |
| 2023-08-08 | 16:12 ET | [10-Q](/filings/0001576885-23-000050.md) | Quarterly report, period 2023-06-30 | 0001576885-23-000050 |
| 2023-08-08 | 07:33 ET | [8-K](/filings/0001576885-23-000047.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576885-23-000047 |
| 2023-07-25 | 16:31 ET | [SC 13D/A](/filings/0001104659-23-083859.md) | Ownership report, active investor, amended | 0001104659-23-083859 |

Page 1 of 2. [Older](/companies/abos/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 07:07 ET. No prices; not investment advice.